Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT04839016 · UNKNOWN
Trial details
- NCT number
- NCT04839016
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-25
- Primary completion
- 2023-08-30
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.